AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Kishvog-MV2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Kishri Pharma Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Kishvog-MV2 Tablet SR

Diabeva-Duo SR tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabeva-Duo SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated blood glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect. Familiarize yourself with hypoglycemia symptoms—sweating, lightheadedness, headache, tremor—and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Kishvog-MV2 Tablet SR

No text provided. Please provide the text you wish me to rewrite.

Uses of Kishvog-MV2 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Kishvog-MV2 Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Kishvog-MV2 Tablet SR whole; avoid chewing, crushing, or fracturing it. Consume it on an empty stomach.

Common Side effects of Kishvog-MV2 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Kishvog-MV2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Kishvog-MV2 Tablet SR. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.

How Kishvog-MV2 Tablet SR works:

Kishvog-MV2 sustained-release tablets contain a triple-drug regimen for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Kishvog-MV2 Tablet SR and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Kishvog-MV2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Kishvog-MV2 Tablet likely poses a risk to breastfeeding infants. Available human data indicates potential drug transfer via breast milk, potentially harming the nursing child.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Employing Kishvog-MV2 Tablet SR in individuals with kidney impairment carries a substantial risk and should be strictly avoided. Medical advice is essential. Furthermore, its use is contraindicated in patients exhibiting severe renal dysfunction.

LiverLiverCAUTION

Exercise caution when prescribing Kishvog-MV2 Tablet SR to patients with hepatic impairment; dosage modification may be necessary. Consult a physician. In individuals with mild to moderate liver disease, initiate Kishvog-MV2 Tablet SR therapy at a reduced dosage; avoid use in patients with severe hepatic dysfunction.

What if you forget to take Kishvog-MV2 Tablet SR :

Should you forget a Kishvog-MV2 Tablet SR dose, take it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual regimen. Never take a double dose.

Facts to Know About Kishvog-MV2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Kishvog-MV2 Tablet SR

Kishvog-MV2 Tablet SR combines glimepiride, metformin, and voglibose to treat type 2 diabetes mellitus in adults. This triple-drug therapy, used alongside diet and exercise, improves blood glucose control. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose levels. This combination is unsuitable for type 1 diabetes.
Kishvog-MV2 Tablet SR may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infection.
Kishvog-MV2 Tablet SR is contraindicated in patients with known allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Kishvog-MV2 Tablet SR and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Kishvog-MV2 Tablet SR can cause low blood sugar (hypoglycemia), leading to symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases if you skip meals, drink alcohol, overexert yourself, or use other diabetes medications concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Kishvog-MV2 Tablet SR
122
MRP 149
17% off